Chronic News and Research

RSS

Study indicates rate of ADHD diagnosis has increased from 2001 to 2010

A study of medical records at the Kaiser Permanente Southern California health plan suggests the rate of attention-deficit/hyperactivity disorder (ADHD) diagnosis increased from 2001 to 2010, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.

22 Jan 2013

Mobile access can greatly improve healthcare services

In contrast to healthcare access, mobile access is becoming almost ubiquitous worldwide. The increasing penetration of smartphones as well as 3G and 4G networks will provide a significant boost to the use of mobile platforms for providing healthcare services. Mobile health (mHealth) stands at a significant inflection point.

22 Jan 2013

Knee replacement pain predicted by comorbidity

Research may help physicians give patients undergoing total knee arthroplasty a realistic expectation of surgery outcome based on their overall physical and mental health, US researchers believe.

21 Jan 2013

Tattooing poses HCV risk

Hepatitis C virus infection is more common in people who have had a tattoo, research shows.

21 Jan 2013

Bladder cancer risk associated with childbearing factors

The risk for bladder cancer in women may decline with increased parity and older age at first birth, researchers report.

21 Jan 2013

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

Itch was actually defined by a German physician more than 350 years ago. His name was Samuel Hafenreffer. He defined itch as an unpleasant sensation that makes people want to scratch. You probably think this is a very simple definition but itch is really a very complex sensory modality.

21 Jan 2013

BonAlive Biomaterials, Olympus Biotech sign multi-year exclusive distribution agreement

BonAlive Biomaterials Ltd, a manufacturer of implantable medical devices and an emerging leader in indications involving the treatment of chronically infected bone, and Olympus Biotech International Ltd, a wholly owned company of Olympus Corporation focused on minimally-invasive regenerative therapies in bone and soft tissues, today announced the signing of a multi-year exclusive distribution agreement.

From Evident Corporation - Life Sciences 21 Jan 2013

Scientists identify new mechanism that turns CD4 helper T lymphocytes into killer cells

A research team led by the La Jolla Institute for Allergy & Immunology has discovered the mechanism that enables CD4 helper T cells to assume the more aggressive role of killer T cells in mounting an immune attack against viruses, cancerous tumors and other damaged or infected cells.

21 Jan 2013

New study: Loneliness can harm overall health

New research links loneliness to a number of dysfunctional immune responses, suggesting that being lonely has the potential to harm overall health.

20 Jan 2013

EMA adopts positive opinion for Pfizer’s bosutinib conditional approval in the EU

Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion regarding the conditional marketing authorization of bosutinib in the European Union for the treatment of adult patients with chronic phase (CP), accelerated phase (AP), and blast phase (BP) Philadelphia chromosome positive chronic myelogenous leukemia previously treated with one or more tyrosine kinase inhibitor(s) (TKIs) and for whom imatinib, nilotinib and dasatinib are not considered appropriate treatment options.

19 Jan 2013

NSU to host conference on neuro immune conditions

Nova Southeastern University (NSU) will be hosting a conference on Saturday, Jan. 26 about the upcoming opening of the NSU College of Osteopathic Medicine's Institute for Neuro Immune Medicine.

19 Jan 2013

New model of tau pathology spread

Brain diseases associated with the misformed protein tau, including Alzheimer's disease and frontotemporal lobar degeneration with tau pathologies, are characterized by neurofibrillary tangles (NFTs) comprised of pathological tau filaments.

19 Jan 2013

CRF to sponsor 8th International Conference on Cell Therapy for Cardiovascular Disease

The final agenda for the Eighth International Conference on Cell Therapy for Cardiovascular Disease, sponsored by the Cardiovascular Research Foundation, is now available online.

19 Jan 2013

Botulinum toxin A more effective than intralesional steroids in treating plantar fasciitis

Plantar fasciitis is the most frequent cause of chronic heel pain, leaving many sufferers unable to put their best foot forward for months at a time. Now a Mexican study suggests that physicians should turn to Botox rather than steroids to offer patients the fastest road to recovery.

18 Jan 2013

Penn Medicine to establish new center for treatment and research of blood diseases

Penn Medicine will establish the Philadelphia region's first dedicated center for the treatment and research of blood diseases by combining the expertise of physicians who specialize in the care of blood disorder patients of all ages along with basic science and clinical researchers who are working to advance treatments for these illnesses.

18 Jan 2013

mTorc1 promotes growth of inflammation-associated colon and gastric cancers

Researchers have identified a complex of proteins that promotes the growth of some types of colon and gastric cancers, and shown that medications that block the function of this complex have the potential to be developed into a new treatment for these diseases.

18 Jan 2013

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Today, Boehringer Ingelheim announced that the first patients have been enrolled in the company's pivotal Phase III interferon (IFN)-free hepatitis C (HCV) clinical trial programme, HCVerso.

18 Jan 2013

Sabutoclax appears to selectively target leukemia stem cells that are responsible for relapses

Researchers at the University of California, San Diego School of Medicine have discovered that hard-to-reach, drug-resistant leukemia stem cells (LSCs) that overexpress multiple pro-survival protein forms are sensitive - and thus vulnerable - to a novel cancer stem cell-targeting drug currently under development.

18 Jan 2013

Rochester scientists propose new reason why acute myeloid leukemia is so difficult to cure

University of Rochester Medical Center scientists have proposed a new reason why acute myeloid leukemia, one of the most aggressive cancers, is so difficult to cure: a subset of cells that drive the disease appear to have a much slower metabolism than most other tumors cells.

18 Jan 2013

Intermountain Risk Score tool can predict mortality among trauma patients

A simple, inexpensive blood test performed on trauma patients upon admission can help doctors easily identify patients at greatest risk of death, according to a new study by researchers at Intermountain Medical Center in Salt Lake City.

18 Jan 2013

Chronic News and Research

Study indicates rate of ADHD diagnosis has increased from 2001 to 2010

Mobile access can greatly improve healthcare services

Knee replacement pain predicted by comorbidity

Tattooing poses HCV risk

Bladder cancer risk associated with childbearing factors

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

BonAlive Biomaterials, Olympus Biotech sign multi-year exclusive distribution agreement

Scientists identify new mechanism that turns CD4 helper T lymphocytes into killer cells

New study: Loneliness can harm overall health

EMA adopts positive opinion for Pfizer’s bosutinib conditional approval in the EU

NSU to host conference on neuro immune conditions

New model of tau pathology spread

CRF to sponsor 8th International Conference on Cell Therapy for Cardiovascular Disease

Botulinum toxin A more effective than intralesional steroids in treating plantar fasciitis

Penn Medicine to establish new center for treatment and research of blood diseases

mTorc1 promotes growth of inflammation-associated colon and gastric cancers

Boehringer Ingelheim initiates enrollment in Phase III IFN-free HCV trial

Sabutoclax appears to selectively target leukemia stem cells that are responsible for relapses

Rochester scientists propose new reason why acute myeloid leukemia is so difficult to cure

Intermountain Risk Score tool can predict mortality among trauma patients

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News